Breaking News Instant updates and real-time market news.

EXAS

Exact Sciences

$22.15

0.63 (2.93%)

17:36
03/01/17
03/01
17:36
03/01/17
17:36

Exact Sciences, Mayo Clinic study 'shows promise' for lung cancer test

A study from Exact Sciences and Mayo Clinic released today by the American Association of Cancer Research shows promise for the development of a blood-based lung cancer test. Researchers conducted a multi-round study of nearly 400 patients, which demonstrated high accuracy for detecting lung cancer at all stages. "These results reveal an opportunity to detect lung cancer from a simple blood draw," said Kevin Conroy, chairman and CEO of Exact Sciences. "Our collaboration with Mayo Clinic is efficiently identifying biomarkers for additional cancer applications on the same technology platform as Cologuard." AACR released an abstract of the study today, ahead of the presentation of the results on April 2, 2017, during the AACR 2017 annual meeting. The findings from the study of 398 patients demonstrate that biomarkers in plasma achieved high accuracy for all types and stages of lung cancer. Using two independent regression modeling approaches, a panel of four novel methylated DNA markers demonstrated a sensitivity of 91%-96% at a specificity of 90%-94%.

EXAS Exact Sciences
$22.15

0.63 (2.93%)

02/22/17
ROTH
02/22/17
UPGRADE
ROTH
Buy
Exact Sciences upgraded to Buy from Neutral at Roth Capital
02/22/17
ADAM
02/22/17
NO CHANGE
Target $27
ADAM
Buy
Exact Sciences remains a top pick at Canaccord
Canaccord analyst Mark Massaro raised his price target on Exact Sciences and said it remains a top pick following solid Q4 results. The analyst cited accelerating trends, which he sees bringing profitability closer to reality. Massaro reiterated his Buy rating and raised his price target to $27 from $24 on Exact Sciences shares.
02/22/17
BARD
02/22/17
NO CHANGE
Target $26
BARD
Outperform
Exact Sciences price target raised to $26 from $22 at Baird
Baird analyst Catherine Ramsey Schulte raised her price target on Exact Sciences to $26 from $22 following Q4 results and better than expected guidance. She believes the company is well positioned for 2017 with the potential for expanded insurance coverage, quality measure inclusion, and continued impact from its national TV ad campaign. Schulte reiterated her Outperform rating on Exact Sciences shares.
02/22/17
02/22/17
UPGRADE
Target $26

Buy
Exact Sciences upgraded to Buy at Roth Capital
As previously reported, Roth Capital analyst Chris Lewis upgraded Exact Sciences to Buy from Neutral after the company announced Q4 revenues in-line with its pre-announcement beat driven by strong volumes and higher ASPs, and unveiled 2017 guidance above expectations. The analyst believes Exact Sciences is well-positioned to sustain its notable commercial launch trajectory over the coming years. Lewis also raised his price target on the shares to $26 from $15.

TODAY'S FREE FLY STORIES

ROIC

Retail Opportunity

$20.14

0.09 (0.45%)

07:40
08/17/17
08/17
07:40
08/17/17
07:40
Upgrade
Retail Opportunity rating change  »

Retail Opportunity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BABA

Alibaba

$159.50

1.75 (1.11%)

07:39
08/17/17
08/17
07:39
08/17/17
07:39
Hot Stocks
Alibaba: 'The numbers speak for themselves' »

Alibaba said on its Q2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

  • 18

    Aug

AAPL

Apple

$160.94

-0.68 (-0.42%)

07:38
08/17/17
08/17
07:38
08/17/17
07:38
Periodicals
Apple Watch may not support voice calls at launch, AI reports »

The new LTE-connected…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

WMT

Wal-Mart

$80.98

0.21 (0.26%)

07:35
08/17/17
08/17
07:35
08/17/17
07:35
Hot Stocks
Breaking Hot Stocks news story on Wal-Mart »

Wal-Mart drops 2.3% in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

  • 16

    Nov

  • 20

    Feb

TDOC

Teladoc

$30.05

-1.15 (-3.69%)

07:35
08/17/17
08/17
07:35
08/17/17
07:35
Recommendations
Teladoc analyst commentary  »

Teladoc to benefit from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 06

    Sep

  • 11

    Sep

AERI

Aerie Pharmaceuticals

$52.20

-0.2 (-0.38%)

07:35
08/17/17
08/17
07:35
08/17/17
07:35
Recommendations
Aerie Pharmaceuticals analyst commentary  »

Aerie Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

  • 28

    Feb

BABA

Alibaba

$159.50

1.75 (1.11%)

, MU

Micron

$30.69

1.01 (3.40%)

07:35
08/17/17
08/17
07:35
08/17/17
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

BABA

Alibaba

$159.50

1.75 (1.11%)

MU

Micron

$30.69

1.01 (3.40%)

FCX

Freeport McMoRan

$14.77

0.8 (5.73%)

VALE

Vale

$10.10

0.32 (3.27%)

RIG

Transocean

$7.58

-0.33 (-4.17%)

MPC

Marathon Petroleum

$51.06

-0.83 (-1.60%)

COTY

Coty

$19.67

0.11 (0.56%)

PAGP

Plains GP Holdings

$20.35

-0.46 (-2.21%)

ETSY

Etsy

$15.60

-0.04 (-0.26%)

FOLD

Amicus

$12.60

0.31 (2.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

  • 18

    Aug

  • 22

    Aug

  • 29

    Aug

  • 29

    Aug

  • 06

    Sep

  • 08

    Nov

REG

Regency Centers

$65.52

0.46 (0.71%)

07:34
08/17/17
08/17
07:34
08/17/17
07:34
Upgrade
Regency Centers rating change  »

Regency Centers upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COMM

CommScope

$32.85

0.01 (0.03%)

07:34
08/17/17
08/17
07:34
08/17/17
07:34
Upgrade
CommScope rating change  »

CommScope upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

MSG

Madison Square Garden

$217.42

1.33 (0.62%)

07:33
08/17/17
08/17
07:33
08/17/17
07:33
Earnings
MSG reports Q4 EPS ($3.58), may not compare to consensus ($1.39) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

ARAY

Accuray

$4.00

-0.1 (-2.44%)

07:32
08/17/17
08/17
07:32
08/17/17
07:32
Hot Stocks
Accuray's Radixact system used by Summit Cancer Center-Boise for the first time »

Accuray and the Summit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

AMOV

America Movil, also tag AMX

$18.51

-0.07 (-0.38%)

, AMX

America Movil, also tag AMOV

$18.82

0.22 (1.18%)

07:32
08/17/17
08/17
07:32
08/17/17
07:32
Periodicals
Mexican Supreme Court rules for America Movil on interconnection fees, WSJ says »

Mexico's Supreme…

AMOV

America Movil, also tag AMX

$18.51

-0.07 (-0.38%)

AMX

America Movil, also tag AMOV

$18.82

0.22 (1.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GDEN

Golden Entertainment

$21.41

0.23 (1.09%)

07:31
08/17/17
08/17
07:31
08/17/17
07:31
Hot Stocks
Golden Entertainment completes syndication of financing to fund American deal »

Golden Entertainment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBR

Petrobras

$8.65

0.06 (0.70%)

, CBI

CB&I

$9.97

-1.22 (-10.90%)

07:30
08/17/17
08/17
07:30
08/17/17
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

PBR

Petrobras

$8.65

0.06 (0.70%)

CBI

CB&I

$9.97

-1.22 (-10.90%)

URBN

Urban Outfitters

$19.76

2.94 (17.48%)

CL

Colgate-Palmolive

$71.93

0.13 (0.18%)

AXON

Axovant Sciences

$21.80

-0.83 (-3.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

CSCO

Cisco

$32.34

0.25 (0.78%)

07:28
08/17/17
08/17
07:28
08/17/17
07:28
Recommendations
Cisco analyst commentary  »

Cisco stock likely range…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

LB

L Brands

$38.95

0.5 (1.30%)

07:28
08/17/17
08/17
07:28
08/17/17
07:28
Recommendations
L Brands analyst commentary  »

L Brands share losses may…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

CSCO

Cisco

$32.34

0.25 (0.78%)

07:28
08/17/17
08/17
07:28
08/17/17
07:28
Recommendations
Cisco analyst commentary  »

Cisco 'slowly moving…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

CCL

Carnival

$68.87

0.16 (0.23%)

07:28
08/17/17
08/17
07:28
08/17/17
07:28
Recommendations
Carnival analyst commentary  »

Carnival price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QTNA

Quantenna Communications

$17.79

-0.23 (-1.28%)

07:27
08/17/17
08/17
07:27
08/17/17
07:27
Conference/Events
Quantenna Communications management to meet with Deutsche Bank »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

  • 23

    Aug

  • 12

    Sep

  • 08

    Nov

MOH

Molina Healthcare

$56.78

-0.25 (-0.44%)

07:27
08/17/17
08/17
07:27
08/17/17
07:27
Upgrade
Molina Healthcare rating change  »

Molina Healthcare…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PDCO

Patterson Companies

$37.29

0.54 (1.47%)

, HSIC

Henry Schein

$170.31

2.37 (1.41%)

07:26
08/17/17
08/17
07:26
08/17/17
07:26
Recommendations
Patterson Companies, Henry Schein analyst commentary  »

Patterson Companies price…

PDCO

Patterson Companies

$37.29

0.54 (1.47%)

HSIC

Henry Schein

$170.31

2.37 (1.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 18

    Sep

NOV

National Oilwell

$29.94

-0.45 (-1.48%)

07:23
08/17/17
08/17
07:23
08/17/17
07:23
Upgrade
National Oilwell rating change  »

National Oilwell upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

MOH

Molina Healthcare

$56.78

-0.25 (-0.44%)

, UNH

UnitedHealth

$193.77

-0.73 (-0.38%)

07:23
08/17/17
08/17
07:23
08/17/17
07:23
Periodicals
Trump administration to make health-insurer payments in August, WSJ reports »

The Trump administration…

MOH

Molina Healthcare

$56.78

-0.25 (-0.44%)

UNH

UnitedHealth

$193.77

-0.73 (-0.38%)

CNC

Centene

$82.87

0.02 (0.02%)

WCG

WellCare

$174.64

0.53 (0.30%)

CI

Cigna

$179.86

0.7 (0.39%)

ANTM

Anthem

$193.35

0.36 (0.19%)

HNT

Health Net

HUM

Humana

$247.36

0.53 (0.21%)

AET

Aetna

$155.90

0.14 (0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 26

    Sep

  • 27

    Sep

  • 08

    Nov

LANC

Lancaster Colony

$124.41

0.12 (0.10%)

07:22
08/17/17
08/17
07:22
08/17/17
07:22
Hot Stocks
Lancaster Colony CEO provides FY18 outlook »

Lancaster Colony CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

  • 30

    Aug

LANC

Lancaster Colony

$124.41

0.12 (0.10%)

07:21
08/17/17
08/17
07:21
08/17/17
07:21
Earnings
Lancaster Colony reports Q4 EPS $1.04, consensus $1.12 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

  • 30

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.